ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
QLHC Concludes Apremilast Not Likely to Reduce Time to COVID Recovery, Mortality
March 22, 2021Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, announced that apremilast (Otezla), made by Amgen, has been dropped for futility. -
Unichem Laboratories gets USFDA approval for Apremilast Tablets
February 20, 2021Unichem Laboratories has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen’s Otezla (apremilast) Tablets, 10 mg, 20 mg, and 30 mg. -
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
July 22, 2019FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease.
Pharma Sources Insight January 2025
